# Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window

> **NCT07476898** · PHASE3 · NOT_YET_RECRUITING · sponsor: **First Hospital of China Medical University** · enrollment: 864 (estimated)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Tenecteplase (0.25mg/kg)
- **DRUG:** Standard Medical Management

## Key facts

- **NCT ID:** NCT07476898
- **Lead sponsor:** First Hospital of China Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2028-07-01
- **Final completion:** 2028-08-01
- **Target enrollment:** 864 (ESTIMATED)
- **Last updated:** 2026-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07476898

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07476898, "Precision Reperfusion Therapy for Disabling Minor Stroke With Large Vessel Occlusion Beyond Time Window". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07476898. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*